{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:24:23Z","timestamp":1785536663540,"version":"3.56.0"},"reference-count":45,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccination is an effective tool to limit equine influenza virus (EIV H3N8) infection, a contagious respiratory disease with potentially huge economic impact. The study assessed the effects of antigenic change on vaccine efficacy and the need for strain update. Horses were vaccinated (V1 and V2) with an ISCOMatrix-adjuvanted, whole inactivated virus vaccine (Equilis Prequenza, group 2, FC1 and European strains) or a carbomer-adjuvanted, modified vector vaccine (ProteqFlu, group 3, FC1 and FC2 HA genes). Serology (SRH, HI, VN), clinical signs and viral shedding were assessed in comparison to unvaccinated control horses. The hypothesis was that group 2 (no FC2 vaccine strain) would be less well protected than group 3 following experimental infection with a recent FC2 field strain (A\/equi-2\/Wexford\/14) 4.5 months after vaccination. All vaccinated horses had antibody titres to FC1 and FC2. After challenge, serology increased more markedly in group 3 than in group 2. Vaccinated horses had significantly lower total clinical scores and viral shedding. Unexpectedly, viral RNA shedding was significantly lower in group 2 than in group 3. Vaccination induced protective antibody titres to FC1 and FC2 and reduced clinical signs and viral shedding. The two tested vaccines provided equivalent protection against a recent FC2 EIV field strain.<\/jats:p>","DOI":"10.3390\/vaccines8030501","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T08:40:26Z","timestamp":1599122426000},"page":"501","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Determining Equine Influenza Virus Vaccine Efficacy\u2014The Specific Contribution of Strain Versus Other Vaccine Attributes"],"prefix":"10.3390","volume":"8","author":[{"given":"Sylvia","family":"Reemers","sequence":"first","affiliation":[{"name":"MSD Animal Health, Wim de K\u00f6rverstraat 35, 5831 AN Boxmeer, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny","family":"Sonnemans","sequence":"additional","affiliation":[{"name":"MSD Animal Health, Wim de K\u00f6rverstraat 35, 5831 AN Boxmeer, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Horspool","sequence":"additional","affiliation":[{"name":"MSD Animal Health, Wim de K\u00f6rverstraat 35, 5831 AN Boxmeer, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"van Bommel","sequence":"additional","affiliation":[{"name":"MSD Animal Health, Wim de K\u00f6rverstraat 35, 5831 AN Boxmeer, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-4719","authenticated-orcid":false,"given":"Qi","family":"Cao","sequence":"additional","affiliation":[{"name":"MSD Animal Health, Wim de K\u00f6rverstraat 35, 5831 AN Boxmeer, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"van de Zande","sequence":"additional","affiliation":[{"name":"MSD Animal Health, Wim de K\u00f6rverstraat 35, 5831 AN Boxmeer, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"ref_1","unstructured":"Sellon, D.C., and Long, M.T. (2013). Equine influenza infection. Equine Infectious Diseases, Saunders Elsevier. [2nd ed.]."},{"key":"ref_2","unstructured":"The World Organisation for Animal Health (OIE) (2019, August 01). Information on Aquatic and Terrestrial Animal Diseases, Equine Influenza. Available online: https:\/\/www.oie.int\/en\/animal-health-in-the-world\/animal-diseases\/equine-influenza."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1751-0813.2011.00721.x","article-title":"Overview of the 2007 Australian outbreak of equine influenza","volume":"89","author":"Webster","year":"2011","journal-title":"Aust. Vet. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/vaccines2040797","article-title":"A systematic review of recent advances in equine influenza vaccination","volume":"2","author":"Paillot","year":"2014","journal-title":"Vaccines"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.vetmic.2013.04.027","article-title":"Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A\/eq2\/Richmond\/1\/07","volume":"166","author":"Paillot","year":"2013","journal-title":"Vet. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.2042-3306.2010.00333.x","article-title":"Management and environmental factors involved in equine influenza outbreaks in Ireland 2007\u20132010","volume":"43","author":"Gildea","year":"2011","journal-title":"Equine Vet. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1016\/j.vaccine.2011.09.101","article-title":"A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings\u2014A randomised blind study","volume":"29","author":"Gildea","year":"2011","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.vetmic.2013.03.029","article-title":"Equine influenza\u2014A global perspective","volume":"167","author":"Cullinane","year":"2013","journal-title":"Vet. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tvjl.2010.06.026","article-title":"Equine influenza: A review of an unpredictable virus","volume":"189","author":"Daly","year":"2011","journal-title":"Vet. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/088282403763635456","article-title":"Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses","volume":"16","author":"Wattrang","year":"2003","journal-title":"Viral Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1016\/j.vaccine.2011.03.003","article-title":"A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of national hunt horses\u2014A randomised blind study","volume":"29","author":"Gildea","year":"2011","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.vetmic.2012.10.019","article-title":"Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity","volume":"162","author":"Paillot","year":"2013","journal-title":"Vet. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tvjl.2007.06.012","article-title":"Boosting in equine influenza vaccination schedules: Timing and time for a re-evaluation of requirements of national and international authorities","volume":"174","author":"Wood","year":"2007","journal-title":"Vet. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1128\/JVI.03379-12","article-title":"Evolution of equine influenza virus in vaccinated horses","volume":"87","author":"Murcia","year":"2013","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"(2020, June 01). OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition, OIE Headquarters, 16 April 2020. Conclusions and Recommendations. Available online: https:\/\/www.oie.int\/scientific-expertise\/specific-information-and-recommendati.;ons\/equine-influenza\/.","DOI":"10.20506\/bull.2020.1.3134"},{"key":"ref_16","first-page":"153","article-title":"Analysis of antigenic variation in equine 2 influenza A viruses","volume":"61","author":"Hinshaw","year":"1983","journal-title":"Bull. WHO"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1750-2659.2010.00176.x","article-title":"Equine influenza\u2014Surveillance and control","volume":"4","author":"Cullinane","year":"2010","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_19","first-page":"9","article-title":"The Equine Influenza Expert Surveillance Panel","volume":"5","author":"Mumford","year":"2009","journal-title":"AHT\/BEVA\/DEFRA Equine Q. Dis. Surveill. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01341723","article-title":"Antigenic Properties of Some Equine Influenza Viruses","volume":"73","author":"Burrows","year":"1982","journal-title":"Arch. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/evj.12171","article-title":"Equine influenza vaccines in Europe: A view from the animal health industry","volume":"45","author":"Horspool","year":"2013","journal-title":"Equine Vet. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1016\/j.vaccine.2009.02.085","article-title":"An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens","volume":"27","author":"Poetri","year":"2009","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/03079450600597956","article-title":"Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus","volume":"35","author":"Swayne","year":"2006","journal-title":"Avian Pathol."},{"key":"ref_24","unstructured":"The European Medicines Agency (EMA) (2019, August 01). EMA\/CVMP\/IWP\/97961\/2013, Guideline on Data Requirements for Changes to the Strain Composition of Authorised Equine Influenza Vaccines in Line with Oie Recommendations. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-data-requirements-changes-strain-composition-authorised-equine-influenza-vaccines-line_en.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Paillot, R., Rash, N.L., Garrett, D., Prowse-Davis, L., Montesso, F., llinane, A., Lemaitre, L., Thibault, J.C., Wittreck, S., and Dancer, A. (2016). How to meet the last OIE expert surveillance panel recommendations on equine influenza (EI) vaccine composition: A review of the process required for the recombinant canarypox-based EI vaccine. Pathogens, 5.","DOI":"10.3390\/pathogens5040064"},{"key":"ref_26","unstructured":"(2017). Equine influenza vaccine (inactivated) monograph 0249. European Pharmacopoeia, Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM). [9th ed.]."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1051\/vetres:2007062","article-title":"Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host","volume":"39","author":"Paillot","year":"2008","journal-title":"Vet. Res."},{"key":"ref_28","unstructured":"The World Organisation for Animal Health (OIE) (2019, August 01). Equine Influenza: Chapter 3.5.7. Available online: http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Health_standards\/tahm\/3.05.07_EQ_INF.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1750-2659.2010.00163.x","article-title":"A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus","volume":"4","author":"Gildea","year":"2010","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/evj.12214","article-title":"Comparison of primary vaccination regimes for equine influenza: Working towards an evidence-based regime","volume":"46","author":"Cullinane","year":"2014","journal-title":"Equine Vet. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/vr.101993","article-title":"Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge","volume":"174","author":"Pouwels","year":"2014","journal-title":"Vet. Rec."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gildea, S., Garvey, M., Lyons, P., Lyons, R., Gahan, J., Walsh, C., and Cullinane, A. (2018). Multifocal Equine Influenza Outbreak with Vaccination Breakdown in Thoroughbred Racehorses. Pathogens, 7.","DOI":"10.3390\/pathogens7020043"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vetmic.2006.11.017","article-title":"An outbreak of equine influenza virus in vaccinated horses in Italy is due to an H3N8 strain closely related to recent North American representatives of the Florida sub-lineage","volume":"121","author":"Martella","year":"2007","journal-title":"Vet. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/vr.158.6.185","article-title":"Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease","volume":"158","author":"Newton","year":"2006","journal-title":"Vet. Rec."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.vetmic.2008.06.009","article-title":"Vaccine failure caused an outbreak of equine influenza in Croatia","volume":"133","author":"Barbic","year":"2009","journal-title":"Vet. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetmic.2016.03.006","article-title":"Controlling equine influenza: Traditional to next generation serological assays","volume":"187","author":"Kinsley","year":"2016","journal-title":"Vet. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1292\/jvms.17-0538","article-title":"Neutralization antibody response to booster\/priming immunization with new equine influenza vaccine in Japan","volume":"80","author":"Yamanaka","year":"2018","journal-title":"J. Vet. Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0378-1135(94)00105-6","article-title":"The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses","volume":"45","author":"Morley","year":"1995","journal-title":"Vet. Microbiol."},{"key":"ref_39","first-page":"335","article-title":"Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. Antiviral activities of the antibodies in biological systems","volume":"88","author":"Haaheim","year":"1980","journal-title":"Acta Pathol. Microbiol. Scand. B"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.vetimm.2006.02.007","article-title":"Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus","volume":"112","author":"Paillot","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-2659.2008.00038.x","article-title":"Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs","volume":"2","author":"Geeraedts","year":"2008","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stoel, M., Pool, J., de Vries-Idema, J., Zaaraoui-Boutahar, F., Bijl, M., Andeweg, A.C., Wilschut, J., and Huckriede, A. (2015). Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125228"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Budimir, N., Huckriede, A., Meijerhof, T., Boon, L., Gostick, E., Price, D.A., Wilschut, J., and de Haan, A. (2012). Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: The role of viral membrane fusion activity. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030898"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Rappuoli","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1016\/j.vaccine.2015.04.099","article-title":"Molecular signatures of vaccine adjuvants","volume":"33","author":"Olafsdottir","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/501\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:12Z","timestamp":1760177172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["vaccines8030501"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8030501","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}